Softwr

Healthcare · head to head

Annalise.ai vs Sectra

Annalise.ai logo

Annalise.ai

Healthcare

Multi-finding chest X-ray and head CT triage AI with FDA clearance on named findings, not on the whole model

From
On request
Rated
-
Full reviewWebsite
Sectra logo

Sectra

Healthcare

Enterprise imaging and PACS from a Swedish vendor that also sells the pathology and cardiology modules on one platform

From
On request
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: Annalise.ai the United States cleared indication covers roughly ten findings for triage and notification, far fewer than the model reports, so a buyer who evaluates the full multi-finding output and then contracts in the United States gets a much narrower cleared use.; Sectra sectra does not make scanners, so it cannot cross-subsidise software against modality hardware the way an integrated manufacturer can, and it often loses on headline price in a bundled tender.
  • They diverge on capability: Annalise.ai covers Annalise Enterprise CXR, Sectra covers Sectra IDS7.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Annalise.ai and Sectra actually diverge.

Attributes where Annalise.ai and Sectra differ
AttributeAnnalise.aiSectra
PlatformsWeb, Cloud, On-premiseWindows, Web, Cloud, On-premise

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Annalise.ai

  • Annalise Enterprise CXR
  • Annalise Enterprise CTB
  • Triage and notification
  • Worklist reprioritisation
  • Localisation overlays
  • Confidence output
  • PACS-native deployment
  • On-premise or cloud inference

Only in Sectra

  • Sectra IDS7
  • Digital pathology module
  • Sectra VNA
  • Sectra UniView
  • Image Exchange Portal
  • Sectra Amplifier
  • Breast imaging workflow
  • Sectra One Cloud

What people use each for

The jobs each tool is most often brought in to do.

Annalise.ai

  • An emergency department wanting pneumothorax and intracranial haemorrhage pushed to the front of the reading queue overnight when cover is thinnestnot Sectra
  • A teleradiology provider covering many small hospitals that needs consistent triage before a human readsnot Sectra
  • A screening programme in Europe where the broader CE marked decision support indication, rather than the narrow United States triage clearance, is what is being deployednot Sectra
  • A radiology department building an AI governance programme that wants one vendor covering both chest radiograph and head CT rather than contracting two separate algorithm suppliersnot Sectra

Sectra

  • A hospital group digitising histopathology that does not want a second image archive and a second integration project alongside radiologynot Annalise.ai
  • A regional health service replacing several departmental PACS with one archive and one clinician viewernot Annalise.ai
  • An imaging provider moving off a capital refresh cycle to a cloud subscription with predictable annual costnot Annalise.ai
  • A trust that needs to send and receive studies with neighbouring organisations routinely, where the Image Exchange Portal is already the regional normnot Annalise.ai

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Annalise.ai

  • The United States cleared indication covers roughly ten findings for triage and notification, far fewer than the model reports, so a buyer who evaluates the full multi-finding output and then contracts in the United States gets a much narrower cleared use.
  • Triage AI reprioritises a worklist but does not change clinical decisions on its own, so departments that do not redesign how urgent studies are picked up see no measurable improvement in time to treatment.
  • Published validation is largely reader study evidence on detection of individual findings; prospective evidence of shorter time to treatment in routine emergency care is thin.
  • The Annalise brand is being migrated under the Harrison.ai name for the critical care offering, which creates ambiguity in multi-year contracts about what product name is actually being supported.
  • A high finding count raises the alert burden, and departments report that low prevalence findings generate false positives that erode radiologist trust unless the alerting thresholds are tuned locally.

Sectra

  • Sectra does not make scanners, so it cannot cross-subsidise software against modality hardware the way an integrated manufacturer can, and it often loses on headline price in a bundled tender.
  • Diagnostic AI is not built in house; Amplifier orchestrates third party algorithms, so the algorithms themselves need separate licences, separate clinical validation and separate information governance sign off.
  • Sectra One Cloud is priced against a committed annual study volume, and organisations whose imaging activity grows faster than forecast meet overage charges partway through the term.
  • The pathology module assumes you have already solved slide scanning and laboratory workflow, which is the larger and more expensive part of digitising histopathology and is not in Sectra scope.
  • Depth of Epic and Oracle Health integration varies by region and by which modules you buy, so a reference site in Sweden is a weak predictor of what integration will cost a United States buyer.

Pricing, plan by plan

Annalise.ai

On request
  • Annalise Enterprise$undefined/year
    • Priced per study analysed or as an annual volume subscription
    • CXR and CTB licensed separately
    • Cleared finding set differs by market, which changes what you are buying

Sectra

On request
  • Sectra Enterprise Imaging$undefined/year
    • Perpetual licence plus annual maintenance, or Sectra One Cloud subscription
    • Priced on committed annual study volume and modules selected
    • Pathology, cardiology and ophthalmology licensed as separate modules

Which should you pick?

Choose Annalise.ai if

  • You need annalise enterprise cxr.
  • You work on Web, Cloud, On-premise.
  • You also want annalise enterprise ctb.
Annalise.ai review

Choose Sectra if

  • You need sectra ids7.
  • You work on Windows, Web, Cloud, On-premise.
  • You also want digital pathology module.
Sectra review

Questions people ask

Is Annalise.ai or Sectra better?
Neither clearly leads. Annalise.ai starts at On request and Sectra at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Annalise.ai or Sectra?
Annalise.ai starts at On request and Sectra at On request.
Does Annalise.ai or Sectra run on more platforms?
Annalise.ai runs on Web, Cloud, On-premise. Sectra runs on Windows, Web, Cloud, On-premise.
What is Annalise.ai best used for?
Annalise.ai is most often used for an emergency department wanting pneumothorax and intracranial haemorrhage pushed to the front of the reading queue overnight when cover is thinnest, a teleradiology provider covering many small hospitals that needs consistent triage before a human reads, a screening programme in europe where the broader ce marked decision support indication, rather than the narrow united states triage clearance, is what is being deployed, a radiology department building an ai governance programme that wants one vendor covering both chest radiograph and head ct rather than contracting two separate algorithm suppliers. Of those, an emergency department wanting pneumothorax and intracranial haemorrhage pushed to the front of the reading queue overnight when cover is thinnest and a teleradiology provider covering many small hospitals that needs consistent triage before a human reads are not what Sectra is typically brought in for.
What can Annalise.ai do that Sectra cannot?
Annalise.ai covers Annalise Enterprise CXR, Annalise Enterprise CTB, Triage and notification, Worklist reprioritisation. Sectra covers Sectra IDS7, Digital pathology module, Sectra VNA, Sectra UniView.

Answered from the vendors’ own pages

Annalise.ai: How many findings are FDA cleared?

Around ten across chest X-ray and head CT, for triage and notification only. The model reports far more findings than that; the rest are not cleared in the United States.

Sectra: Does Sectra include diagnostic AI?

No. Sectra Amplifier is a marketplace and orchestration layer for third party algorithms, each licensed and validated separately.

Annalise.ai: Is the European position different?

Yes. CE marking under the medical device regulation covers a broader decision support indication than the United States triage and notification clearances, so the same software is a different regulatory product depending on where you deploy it.

Sectra: Is pathology really on the same platform as radiology?

Yes, the pathology module uses the same archive and workflow engine, which is the main reason buyers digitising histopathology shortlist Sectra.

Annalise.ai: Does it diagnose?

No. In the United States it is a triage and notification device: it flags studies for earlier review, and the radiologist makes the diagnosis.

Sectra: How is Sectra One Cloud priced?

On committed annual study volume plus the modules selected, as a subscription rather than a capital purchase. The vendor does not publish rates.

Annalise.ai: Is Annalise.ai becoming Harrison.ai?

The critical care offering is now marketed under the Harrison.ai name. Ask the vendor to name the contracted product explicitly before signing a multi-year deal.

Sectra: Is Sectra CE marked and FDA cleared?

The diagnostic viewing software carries CE marking under the medical device regulation and FDA 510(k) clearance for diagnostic interpretation, but the exact cleared indications differ per module and per market, so confirm for pathology specifically.

Share

Related pages

More on Annalise.ai

More on Sectra

Keep looking

Other head to heads